首页|PARP抑制剂在乳腺癌应用中的现状及前景

PARP抑制剂在乳腺癌应用中的现状及前景

扫码查看
PARP抑制剂可通过合成致死、PARP-DNA捕获等机制对恶性肿瘤产生抑制效果,在治疗包括乳腺癌在内的多种恶性肿瘤患者中取得巨大进展。通过对BRCA基因与乳腺癌、PARP抑制剂抗肿瘤分子机制及其在乳腺癌应用中的情况作一简单综述,以期提高人们对PARP抑制剂的认识,并且为未来临床应用提供参考。
Current Status and Prospects of PARP Inhibitors in Breast Cancer Applications
PARP inhibitors can produce inhibitory effects on malignant tumors through mechanisms such as synthetic lethality and PARP-DNA capture,and have made great progress in the treatment of patients with a variety of malignant tumors,including breast cancer.In this paper,we briefly review the BRCA gene and breast cancer,the anti-tumor molecular mechanism of PARP inhibitors and their application in breast cancer,with a view to improving the understanding of PARP inhibitors and providing references for future clinical applications.

breast cancerPARP inhibitormolecular targeted therapy

蓝天琪、韦京辰

展开 >

桂林医学院药学院,广西桂林 541000

乳腺癌 PARP抑制剂 分子靶向治疗

2024

山东化工
山东省化工研究院 山东省化工信息中心

山东化工

影响因子:0.249
ISSN:1008-021X
年,卷(期):2024.53(12)
  • 24